CA Stock MarketDetailed Quotes
MOOD Doseology Sciences Inc
- 0.220
- 0.0000.00%
15min DelayMarket Closed Oct 24 11:39 ET
968.11KMarket Cap-880P/E (TTM)
0.000High0.000Low0Volume0.000Open0.220Pre Close0.00Turnover0.66052wk High0.00%Turnover Ratio4.40MShares0.07052wk Low-0.25EPS TTM931.15KFloat Cap4.000Historical HighLossP/E (Static)4.23MShs Float0.050Historical Low-0.4EPS LYR0.00%Amplitude--Dividend TTM0.85P/B1Lot Size--Div YieldTTM
Doseology Sciences Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 245.14%33.85K | -22.18%13.27K | 792.91%46.1K | 168.49%43.09K | -19.05%11.06K | 311.06%9.81K | 17.06K | 5.16K | 16.05K | 13.66K |
| Operating revenue | 245.14%33.85K | -22.18%13.27K | 792.91%46.1K | 168.49%43.09K | -19.05%11.06K | 311.06%9.81K | --17.06K | --5.16K | --16.05K | --13.66K |
| Cost of revenue | 302.41%29.61K | -75.48%2.76K | 65.00%17.29K | -98.90%1.8K | -116.76%-27.29K | 351.13%7.36K | 11.25K | 10.48K | 164.43K | 162.8K |
| Gross profit | 73.14%4.24K | 81.14%10.52K | 642.37%28.82K | 127.82%41.29K | 125.71%38.34K | 224.50%2.45K | 5.81K | -5.31K | -148.38K | -149.13K |
| Operating expense | -66.03%51.98K | -47.90%149.38K | -63.93%113.24K | -47.64%873.46K | -60.30%130.79K | -70.90%153K | -44.47%286.74K | 5.73%313.99K | 6.44%1.67M | -46.53%329.47K |
| Selling and administrative expenses | -57.90%29.64K | -37.35%118.39K | -63.83%80.92K | -31.74%682.06K | 9.59%210.03K | -79.59%70.41K | -30.45%188.97K | 17.19%223.71K | 44.66%999.2K | -24.74%191.65K |
| -Selling and marketing expense | -181.32%-5.92K | -28.02%51.57K | -18.74%41.96K | -9.65%172.91K | 219.88%42.34K | -88.22%7.28K | -14.21%71.65K | 57.51%51.63K | 12.41%191.38K | -77.94%13.24K |
| -General and administrative expense | -43.66%35.56K | -43.05%66.82K | -77.36%38.96K | -36.97%509.16K | -6.01%167.69K | -77.70%63.12K | -37.66%117.33K | 8.83%172.08K | 55.21%807.82K | -8.34%178.42K |
| Research and development costs | ---- | ---- | ---- | -99.19%500 | ---- | ---- | ---- | ---- | -45.09%61.72K | -36.63%7.76K |
| Depreciation amortization depletion | -97.15%797 | -97.16%797 | -36.45%17.98K | -52.63%66.09K | -165.44%-18.24K | -17.85%27.98K | -40.32%28.07K | -8.06%28.29K | 50.30%139.53K | -16.39%27.88K |
| -Depreciation and amortization | -97.15%797 | -97.16%797 | -36.45%17.98K | -52.63%66.09K | -165.44%-18.24K | -17.85%27.98K | -40.32%28.07K | -8.06%28.29K | 50.30%139.53K | -16.39%27.88K |
| Other operating expenses | -60.56%21.54K | -56.67%30.2K | -76.85%14.35K | -73.32%124.8K | -160.18%-61.49K | -61.41%54.62K | -60.26%69.7K | 27.14%61.98K | -30.31%467.81K | -67.66%102.19K |
| Operating profit | 68.29%-47.73K | 50.57%-138.87K | 73.56%-84.43K | 54.19%-832.17K | 80.68%-92.45K | 71.32%-150.55K | 45.59%-280.93K | -7.52%-319.3K | -15.91%-1.82M | 22.33%-478.61K |
| Net non-operating interest income (expenses) | -68.01%7.2K | 304.92%8.45K | 138.84%6.34K | 141.93%28.9K | 246.87%26.86K | 279.81%22.5K | 83.12%-4.12K | -19.04%-16.33K | -5.60%-68.94K | -29.39%-18.29K |
| Non-operating interest income | -82.10%7.2K | -40.12%8.45K | 163.70%6.34K | 851.43%65.04K | 1,232.85%8.32K | 654.35%40.21K | --14.11K | -29.58%2.41K | 126.51%6.84K | -79.32%624 |
| Non-operating interest expense | --0 | --0 | --0 | -52.31%36.14K | -198.05%-18.54K | -0.73%17.71K | -25.34%18.23K | 9.35%18.73K | 10.95%75.77K | 10.26%18.91K |
| Other net income (expenses) | 18.77K | -1,720.35%-978.28K | -1,830.50%-984.71K | 17.49K | -4.45K | -995.68%-53.74K | -51.01K | |||
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---4.45K | ---- | ---- |
| Special income (charges) | --0 | --18.77K | ---- | -1,720.35%-978.28K | -1,806.52%-972.48K | ---5.8K | --0 | ---- | -995.68%-53.74K | ---51.01K |
| -Less:Impairment of capital assets | ---- | ---- | ---- | -75.68%12.45K | ---- | ---- | ---- | ---- | --51.21K | ---- |
| -Less:Other special charges | ---- | ---18.77K | ---- | ---120.22K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Less:Write off | ---- | ---- | ---- | --833.25K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Gain on sale of property,plant,equipment | --0 | ---- | ---- | -9,880.02%-252.79K | -123,598.50%-247K | ---5.8K | ---- | ---- | ---2.53K | --200 |
| Other non-operating income (expenses) | ---- | ---- | ---- | ---- | ---- | --23.29K | ---- | ---- | ---- | ---- |
| Income before tax | 63.34%-40.54K | 60.83%-111.64K | 77.04%-78.09K | 8.14%-1.78M | -91.69%-1.05M | 79.43%-110.56K | 47.53%-285.06K | -9.46%-340.07K | -19.23%-1.94M | 13.08%-547.9K |
| Income tax | 0 | 0 | 0 | -96.76K | ||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 63.34%-40.54K | 40.71%-111.64K | 77.04%-78.09K | 8.14%-1.78M | -109.35%-1.15M | 79.43%-110.56K | 65.34%-188.3K | -9.46%-340.07K | -19.23%-1.94M | 13.08%-547.9K |
| Net income continuous operations | 63.34%-40.54K | 40.71%-111.64K | 77.04%-78.09K | 8.14%-1.78M | -109.35%-1.15M | 79.43%-110.56K | 65.34%-188.3K | -9.46%-340.07K | -19.23%-1.94M | 13.08%-547.9K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 63.34%-40.54K | 40.71%-111.64K | 77.04%-78.09K | 8.14%-1.78M | -109.35%-1.15M | 79.43%-110.56K | 65.34%-188.3K | -9.46%-340.07K | -19.23%-1.94M | 13.08%-547.9K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 63.34%-40.54K | 40.71%-111.64K | 77.04%-78.09K | 8.14%-1.78M | -109.35%-1.15M | 79.43%-110.56K | 65.34%-188.3K | -9.46%-340.07K | -19.23%-1.94M | 13.08%-547.9K |
| Diluted earnings per share | 62.83%-0.01 | 44.62%-0.0254 | 81.00%-0.019 | 20.00%-0.4 | -100.00%-0.2 | 73.10%-0.0269 | 54.19%-0.0458 | -31.97%-0.1 | -26.03%-0.5 | 34.95%-0.1 |
| Basic earnings per share | 62.83%-0.01 | 44.62%-0.0254 | 81.00%-0.019 | 20.00%-0.4 | -100.00%-0.2 | 73.10%-0.0269 | 54.19%-0.0458 | -31.97%-0.1 | -26.03%-0.5 | 34.95%-0.1 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data